Delivery Order SPE2DB20D1109-SPE2DB23FN00F
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,547.51 firm-fixed-price delivery order is for the supply of 4557973807 units of 150 mg/mL medroxyprogesterone, with an ultimate completion date of August 3, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,332.20 firm fixed-price contract is for the delivery of 4,568,260,604 milliliters of the drug medroxyprogesterone 150 mg/mL. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This federal contract award is for the delivery of the pharmaceutical product medroxyprogesterone 150 mg/ml to the Department of Defense (DoD) and its medical facilities. The contract, valued at $2,043.32, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
- This federal contract award, valued at $2,308.11, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564608211 - MEDROXYPROGESTERONE 150 MG/MLML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,207.47 firm fixed-price contract is for the provision of 4564590838 - MEDROXYPROGESTERONE 150 MG/MLML, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The IDC...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,839.57 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/ml. This competitive award, issued on September 4, 2025, carries a firm fixed price structure with performance completion targeted for September 5, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,649.15 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/mL, a hormone-based pharmaceutical product. This non-competitive delivery order, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, utilizes firm fixed-price pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,291.43, is for the supply of 4,568,078,632 milliliters of Medroxyprogesterone 150 mg/mL, a medication used for various medical conditions. The contract has an ultimate completion date of April 30, 2025 and was awarded on April 29, 2025. There is no set-aside designation,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of medroxyprogesterone 150 mg/ml, a medication, with a ceiling value of $1,105.35 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- The Defense Logistics Agency awarded a delivery order valued at $2,769.22 to AmerisourceBergen Drug Corp for the supply of Medroxyprogesterone 150 mg/ml, a synthetic progestin commonly used in hormone replacement therapy and contraceptive applications. The contract employs firm fixed price pricing and was awarded on November 18, 2025, with an ultimate completion date of November 19, 2025. This delivery order is not set aside and was competitively awarded, reflecting AmerisourceBergen's...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN00FDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of medroxyprogesterone 150 mg/ml medical products. The $2,148.29 fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 10, 2022. The contract is not designated with a set-aside. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at $999,999,999 and $750,000 respectively, for providing a comprehensive range of pharmaceutical products and medical supplies to support military, veterans, and other federal healthcare programs. These IDCs enable efficient government procurement of essential medical commodities across multiple therapeutic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 11/9/22 |